246 related articles for article (PubMed ID: 19394138)
21. VEGF regulates TRPC6 channels in podocytes.
Thilo F; Liu Y; Loddenkemper C; Schuelein R; Schmidt A; Yan Z; Zhu Z; Zakrzewicz A; Gollasch M; Tepel M
Nephrol Dial Transplant; 2012 Mar; 27(3):921-9. PubMed ID: 21868397
[TBL] [Abstract][Full Text] [Related]
22. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.
Dai J; Peng L; Fan K; Wang H; Wei R; Ji G; Cai J; Lu B; Li B; Zhang D; Kang Y; Tan M; Qian W; Guo Y
Oncogene; 2009 Sep; 28(38):3412-22. PubMed ID: 19597469
[TBL] [Abstract][Full Text] [Related]
23. TRPC1 is essential for in vivo angiogenesis in zebrafish.
Yu PC; Gu SY; Bu JW; Du JL
Circ Res; 2010 Apr; 106(7):1221-32. PubMed ID: 20185799
[TBL] [Abstract][Full Text] [Related]
24. Friend erythroleukemia cells induce angiogenesis in chick embryo chorioallantoic membrane and in human umbilical vein endothelial cells.
Pacini S; Punzi T; Gulisano M; Ruggiero M
Biol Res; 2008; 41(1):109-17. PubMed ID: 18769768
[TBL] [Abstract][Full Text] [Related]
25. Chrysin suppresses IL-6-induced angiogenesis via down-regulation of JAK1/STAT3 and VEGF: an in vitro and in ovo approach.
Lin CM; Shyu KG; Wang BW; Chang H; Chen YH; Chiu JH
J Agric Food Chem; 2010 Jun; 58(11):7082-7. PubMed ID: 20443595
[TBL] [Abstract][Full Text] [Related]
26. Pro-angiogenic properties of orosomucoid (ORM).
Irmak S; Oliveira-Ferrer L; Singer BB; Ergün S; Tilki D
Exp Cell Res; 2009 Nov; 315(18):3201-9. PubMed ID: 19651122
[TBL] [Abstract][Full Text] [Related]
27. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.
Hosseini H; Rajabibazl M; Ebrahimizadeh W; Dehbidi GR
Microvasc Res; 2015 Jan; 97():13-8. PubMed ID: 25250517
[TBL] [Abstract][Full Text] [Related]
28. PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis.
Aljada A; O'Connor L; Fu YY; Mousa SA
Angiogenesis; 2008; 11(4):361-7. PubMed ID: 18810647
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the metabolic changes underlying growth factor angiogenic activation: identification of new potential therapeutic targets.
Vizán P; Sánchez-Tena S; Alcarraz-Vizán G; Soler M; Messeguer R; Pujol MD; Lee WN; Cascante M
Carcinogenesis; 2009 Jun; 30(6):946-52. PubMed ID: 19369582
[TBL] [Abstract][Full Text] [Related]
30. In ovo leptin administration inhibits chorioallantoic membrane angiogenesis in female chicken embryos through the STAT3-mediated vascular endothelial growth factor (VEGF) pathway.
Su L; Rao K; Guo F; Li X; Ahmed AA; Ni Y; Grossmann R; Zhao R
Domest Anim Endocrinol; 2012 Jul; 43(1):26-36. PubMed ID: 22417645
[TBL] [Abstract][Full Text] [Related]
31. TRAIL negatively regulates VEGF-induced angiogenesis via caspase-8-mediated enzymatic and non-enzymatic functions.
Na HJ; Hwang JY; Lee KS; Choi YK; Choe J; Kim JY; Moon HE; Kim KW; Koh GY; Lee H; Jeoung D; Won MH; Ha KS; Kwon YG; Kim YM
Angiogenesis; 2014 Jan; 17(1):179-94. PubMed ID: 24097299
[TBL] [Abstract][Full Text] [Related]
32. Differential role of beta-catenin in VEGF and histamine-induced MMP-2 production in microvascular endothelial cells.
Doyle JL; Haas TL
J Cell Biochem; 2009 May; 107(2):272-83. PubMed ID: 19306293
[TBL] [Abstract][Full Text] [Related]
33. Critical effect of VEGF in the process of endothelial cell apoptosis induced by high glucose.
Yang Z; Mo X; Gong Q; Pan Q; Yang X; Cai W; Li C; Ma JX; He Y; Gao G
Apoptosis; 2008 Nov; 13(11):1331-43. PubMed ID: 18780185
[TBL] [Abstract][Full Text] [Related]
34. Okadaic acid promotes angiogenesis via activation of hypoxia-inducible factor-1.
Kim YS; Ahn KH; Kim SY; Jeong JW
Cancer Lett; 2009 Apr; 276(1):102-8. PubMed ID: 19054610
[TBL] [Abstract][Full Text] [Related]
35. Parathyroid hormone stimulates the endothelial expression of vascular endothelial growth factor.
Rashid G; Bernheim J; Green J; Benchetrit S
Eur J Clin Invest; 2008 Nov; 38(11):798-803. PubMed ID: 19021696
[TBL] [Abstract][Full Text] [Related]
36. Anti-endothelial cell IgG from patients with chronic arsenic poisoning induces endothelial proliferation and VEGF-dependent angiogenesis.
Hong CH; Lee CH; Chang LW; Chiou MH; Hsieh MC; Kao YH; Yu HS
Microvasc Res; 2008 Nov; 76(3):194-201. PubMed ID: 18671988
[TBL] [Abstract][Full Text] [Related]
37. Serum vascular endothelial growth factor in cyanotic congenital heart disease functionally contributes to endothelial cell kinetics in vitro.
Hamada H; Ebata R; Higashi K; Tateno S; Niwa K; Honda T; Yasukawa K; Terai M
Int J Cardiol; 2007 Aug; 120(1):66-71. PubMed ID: 17126928
[TBL] [Abstract][Full Text] [Related]
38. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells.
Kumar A; D'Souza SS; Nagaraj SR; Gaonkar SL; Salimath BP; Rai KM
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1221-33. PubMed ID: 19370348
[TBL] [Abstract][Full Text] [Related]
39. Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium.
Berndt S; Perrier d'Hauterive S; Blacher S; Péqueux C; Lorquet S; Munaut C; Applanat M; Hervé MA; Lamandé N; Corvol P; van den Brûle F; Frankenne F; Poutanen M; Huhtaniemi I; Geenen V; Noël A; Foidart JM
FASEB J; 2006 Dec; 20(14):2630-2. PubMed ID: 17065221
[TBL] [Abstract][Full Text] [Related]
40. HoxB5 induces endothelial sprouting in vitro and modifies intussusceptive angiogenesis in vivo involving angiopoietin-2.
Winnik S; Klinkert M; Kurz H; Zoeller C; Heinke J; Wu Y; Bode C; Patterson C; Moser M
Cardiovasc Res; 2009 Aug; 83(3):558-65. PubMed ID: 19403561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
